BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 29661872)

  • 1. Treating Anthrax-Induced Meningitis in Rabbits.
    Ben-Shmuel A; Glinert I; Sittner A; Bar-David E; Schlomovitz J; Brosh T; Kobiler D; Weiss S; Levy H
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29661872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Single and Combined Antibiotic Treatments of Anthrax in Rabbits.
    Weiss S; Altboum Z; Glinert I; Schlomovitz J; Sittner A; Bar-David E; Kobiler D; Levy H
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7497-503. PubMed ID: 26392505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Combination Drug Therapy for Treatment of Antibiotic-Resistant Inhalation Anthrax in a Murine Model.
    Heine HS; Shadomy SV; Boyer AE; Chuvala L; Riggins R; Kesterson A; Myrick J; Craig J; Candela MG; Barr JR; Hendricks K; Bower WA; Walke H; Drusano GL
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28696235
    [No Abstract]   [Full Text] [Related]  

  • 4. Using old antibiotics to treat ancient bacterium-β-lactams for Bacillus anthracis meningitis.
    Sittner A; Ben-Shmuel A; Glinert I; Bar-David E; Schlomovitz J; Kobiler D; Weiss S; Levy H
    PLoS One; 2020; 15(2):e0228917. PubMed ID: 32053632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central Nervous System Antimicrobial Exposure and Proposed Dosing for Anthrax Meningitis.
    Bradley JS; Bulitta JB; Cook R; Yu PA; Iwamoto C; Hesse EM; Chaney D; Yu Y; Kennedy JL; Sue D; Karchmer AW; Bower WA; Hendricks K
    Clin Infect Dis; 2024 Jun; 78(6):1451-1457. PubMed ID: 38412060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clindamycin Protects Nonhuman Primates Against Inhalational Anthrax But Does Not Enhance Reduction of Circulating Toxin Levels When Combined With Ciprofloxacin.
    Vietri NJ; Tobery SA; Chabot DJ; Ingavale S; Somerville BC; Miller JA; Schellhase CW; Twenhafel NA; Fetterer DP; Cote CK; Klimko CP; Boyer AE; Woolfitt AR; Barr JR; Wright ME; Friedlander AM
    J Infect Dis; 2021 Feb; 223(2):319-325. PubMed ID: 32697310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obiltoxaximab (Anthim) for inhalation anthrax.
    Med Lett Drugs Ther; 2018 Sep; 60(1555):150-151. PubMed ID: 30383733
    [No Abstract]   [Full Text] [Related]  

  • 8. Obiltoxaximab Prevents Disseminated Bacillus anthracis Infection and Improves Survival during Pre- and Postexposure Prophylaxis in Animal Models of Inhalational Anthrax.
    Yamamoto BJ; Shadiack AM; Carpenter S; Sanford D; Henning LN; Gonzales N; O'Connor E; Casey LS; Serbina NV
    Antimicrob Agents Chemother; 2016 Oct; 60(10):5796-805. PubMed ID: 27431219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clindamycin and quinolone therapy for Bacillus anthracis Sterne infection in 60Co-gamma-photon-irradiated and sham-irradiated mice.
    Brook I; Germana A; Giraldo DE; Camp-Hyde TD; Bolduc DL; Foriska MA; Elliott TB; Thakar JH; Shoemaker MO; Jackson WE; Ledney GD
    J Antimicrob Chemother; 2005 Dec; 56(6):1074-80. PubMed ID: 16239289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternative pre-approved and novel therapies for the treatment of anthrax.
    Head BM; Rubinstein E; Meyers AF
    BMC Infect Dis; 2016 Nov; 16(1):621. PubMed ID: 27809794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CDC Guidelines for the Prevention and Treatment of Anthrax, 2023.
    Bower WA; Yu Y; Person MK; Parker CM; Kennedy JL; Sue D; Hesse EM; Cook R; Bradley J; Bulitta JB; Karchmer AW; Ward RM; Cato SG; Stephens KC; Hendricks KA
    MMWR Recomm Rep; 2023 Nov; 72(6):1-47. PubMed ID: 37963097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Doxycycline, levofloxacin, and moxifloxacin are superior to ciprofloxacin in treating anthrax meningitis in rabbits and NHP.
    Ben-Shmuel A; Glinert I; Sittner A; Bar-David E; Schlomovitz J; Levy H; Weiss S
    Antimicrob Agents Chemother; 2024 Apr; ():e0161023. PubMed ID: 38687017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotics cure anthrax in animal models.
    Weiss S; Kobiler D; Levy H; Pass A; Ophir Y; Rothschild N; Tal A; Schlomovitz J; Altboum Z
    Antimicrob Agents Chemother; 2011 Apr; 55(4):1533-42. PubMed ID: 21263056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of anthrax infection with combination of ciprofloxacin and antibodies to protective antigen of Bacillus anthracis.
    Karginov VA; Robinson TM; Riemenschneider J; Golding B; Kennedy M; Shiloach J; Alibek K
    FEMS Immunol Med Microbiol; 2004 Jan; 40(1):71-4. PubMed ID: 14734189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of anthrax meningitis.
    Sejvar JJ; Tenover FC; Stephens DS
    Lancet Infect Dis; 2005 May; 5(5):287-95. PubMed ID: 15854884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic Review of Hospital Treatment Outcomes for Naturally Acquired and Bioterrorism-Related Anthrax, 1880-2018.
    Person MK; Cook R; Bradley JS; Hupert N; Bower WA; Hendricks K
    Clin Infect Dis; 2022 Oct; 75(Suppl 3):S392-S401. PubMed ID: 36251553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of ETI-204 monoclonal antibody as an adjunct therapy in a New Zealand white rabbit partial survival model for inhalational anthrax.
    Biron B; Beck K; Dyer D; Mattix M; Twenhafel N; Nalca A
    Antimicrob Agents Chemother; 2015 Apr; 59(4):2206-14. PubMed ID: 25645849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postexposure Prophylaxis and Treatment of Bacillus anthracis Infections: A Systematic Review and Meta-analyses of Animal Models, 1947-2019.
    Kennedy JL; Bulitta JB; Chatham-Stephens K; Person MK; Cook R; Mongkolrattanothai T; Shin E; Yu P; Negron ME; Bower WA; Hendricks K
    Clin Infect Dis; 2022 Oct; 75(Suppl 3):S379-S391. PubMed ID: 36251546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anthrax: safe treatment for children.
    Benavides S; Nahata MC
    Ann Pharmacother; 2002 Feb; 36(2):334-7. PubMed ID: 11847958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective antimicrobial regimens for use in humans for therapy of Bacillus anthracis infections and postexposure prophylaxis.
    Deziel MR; Heine H; Louie A; Kao M; Byrne WR; Basset J; Miller L; Bush K; Kelly M; Drusano GL
    Antimicrob Agents Chemother; 2005 Dec; 49(12):5099-106. PubMed ID: 16304178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.